CONSTELLATION PHARMACEUTICALS
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
CONSTELLATION PHARMACEUTICALS
Industry:
Biotechnology Genetics Medical Pharmaceutical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.constellationpharma.com
Total Employee:
101+
Status:
Closed
Contact:
6177140555
Email Addresses:
[email protected]
Total Funding:
496.2 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Mobile Non Scaleable Content Euro Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS COVID-19
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Constellation Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Constellation Pharmaceuticals
The Column Group
The Column Group investment in Post-IPO Equity - Constellation Pharmaceuticals
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Constellation Pharmaceuticals
Deerfield
Deerfield investment in Series F - Constellation Pharmaceuticals
Hillhouse Capital Group
Hillhouse Capital Group investment in Series F - Constellation Pharmaceuticals
NS Investment
NS Investment investment in Series F - Constellation Pharmaceuticals
The Column Group
The Column Group investment in Series F - Constellation Pharmaceuticals
SR One
SR One investment in Series F - Constellation Pharmaceuticals
Venrock
Venrock investment in Series F - Constellation Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-08 | Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer |
Official Site Inspections
http://www.constellationpharma.com
- Host name: 104.18.28.230
- IP address: 104.18.28.230
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
